ATE720T1 - NEW PROSTAGLAND INDIVIDUALS OF THE DELTA-2,4-11-DESOXY-PGE SERIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS. - Google Patents
NEW PROSTAGLAND INDIVIDUALS OF THE DELTA-2,4-11-DESOXY-PGE SERIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS.Info
- Publication number
- ATE720T1 ATE720T1 AT79102292T AT79102292T ATE720T1 AT E720 T1 ATE720 T1 AT E720T1 AT 79102292 T AT79102292 T AT 79102292T AT 79102292 T AT79102292 T AT 79102292T AT E720 T1 ATE720 T1 AT E720T1
- Authority
- AT
- Austria
- Prior art keywords
- prostagland
- desoxy
- pharmaceuticals
- individuals
- delta
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000003180 prostaglandins Chemical class 0.000 abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- -1 NH4 ion Chemical class 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- 230000002408 ulcerprotective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5428—Acyclic unsaturated phosphonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
The present invention relates to novel prostaglandin derivatives of the formula I <IMAGE> I which are structurally related to the naturally occurring prostaglandins and in which R1 denotes (a) hydrogen or a straight-chain or branched, saturated or unsaturated aliphatic or cycloaliphatic hydrocarbon radical having up to ten carbon atoms or (b) a physiologically acceptable metal or NH4 ion or an ammonium ion which is derived from a primary, secondary or tertiary amine and R2 denotes a straight-chain, aliphatic hydrocarbon radical having up to six carbon atoms and to a process for their manufacture. The compounds of the invention are distinguished in particular by gastric acid secretion-inhibiting and ulcer-protective properties.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782830079 DE2830079A1 (en) | 1978-07-08 | 1978-07-08 | NEW PROSTAGLAND DERIVATIVES OF THE DELTA 2.4-11 DESOXY-PGE SERIES |
EP79102292A EP0007490B1 (en) | 1978-07-08 | 1979-07-05 | Prostaglandin compounds with a delta-2,4-11 deoxy pge structure, a process for their preparation, and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE720T1 true ATE720T1 (en) | 1982-03-15 |
Family
ID=6043884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT79102292T ATE720T1 (en) | 1978-07-08 | 1979-07-05 | NEW PROSTAGLAND INDIVIDUALS OF THE DELTA-2,4-11-DESOXY-PGE SERIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4258057A (en) |
EP (1) | EP0007490B1 (en) |
JP (1) | JPS5536470A (en) |
AT (1) | ATE720T1 (en) |
AU (1) | AU531714B2 (en) |
CA (1) | CA1156226A (en) |
DE (2) | DE2830079A1 (en) |
ES (1) | ES482128A1 (en) |
IL (1) | IL57738A (en) |
ZA (1) | ZA793388B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552898A (en) * | 1982-07-14 | 1985-11-12 | Syntex (U.S.A.) Inc. | [3.2.0]Bicycloheptanone oxime ethers with valuable therapeutic properties |
JPS63131366U (en) * | 1987-02-20 | 1988-08-26 | ||
IN167720B (en) * | 1987-10-02 | 1990-12-08 | Tsuneyoshi Kawate | |
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7312247B2 (en) * | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) * | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US6495719B2 (en) * | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
US20030108512A1 (en) * | 2001-12-10 | 2003-06-12 | Robert Shorr | Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer |
WO2003099272A1 (en) * | 2002-05-22 | 2003-12-04 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
JP2006508986A (en) * | 2002-11-20 | 2006-03-16 | エルラント ゲネ セラペウチクス エルエルシー | Treatment of lung cells with histone deacetylase inhibitors |
CA2587013A1 (en) * | 2004-11-08 | 2006-05-18 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1414383A (en) * | 1972-11-14 | 1975-11-19 | Syntex Corp | Prostatrienoic acid derivatives and process |
DE2460285A1 (en) * | 1973-12-25 | 1975-07-03 | Ono Pharmaceutical Co | TRANS-DELTA HIGH 2-PROSTAGLAND COMPOUNDS, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE |
US4098815A (en) * | 1974-02-15 | 1978-07-04 | Hoechst Aktiengesellschaft | Novel analogues of prostanoic acids not occurring in nature |
US4165437A (en) * | 1976-03-12 | 1979-08-21 | Ono Pharmaceutical Company, Ltd. | Δ3 -Prostaglandin analogs |
US4061670A (en) * | 1976-07-19 | 1977-12-06 | American Cyanamid Company | 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners |
-
1978
- 1978-07-08 DE DE19782830079 patent/DE2830079A1/en not_active Withdrawn
-
1979
- 1979-07-03 ES ES482128A patent/ES482128A1/en not_active Expired
- 1979-07-05 DE DE7979102292T patent/DE2962192D1/en not_active Expired
- 1979-07-05 US US06/054,874 patent/US4258057A/en not_active Expired - Lifetime
- 1979-07-05 AT AT79102292T patent/ATE720T1/en not_active IP Right Cessation
- 1979-07-05 EP EP79102292A patent/EP0007490B1/en not_active Expired
- 1979-07-06 IL IL57738A patent/IL57738A/en unknown
- 1979-07-06 AU AU48714/79A patent/AU531714B2/en not_active Ceased
- 1979-07-06 JP JP8512479A patent/JPS5536470A/en active Pending
- 1979-07-06 CA CA000331330A patent/CA1156226A/en not_active Expired
- 1979-07-06 ZA ZA793388A patent/ZA793388B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL57738A0 (en) | 1979-11-30 |
US4258057A (en) | 1981-03-24 |
CA1156226A (en) | 1983-11-01 |
EP0007490B1 (en) | 1982-02-24 |
EP0007490A2 (en) | 1980-02-06 |
AU531714B2 (en) | 1983-09-01 |
DE2830079A1 (en) | 1980-01-17 |
ZA793388B (en) | 1980-06-25 |
IL57738A (en) | 1983-05-15 |
AU4871479A (en) | 1980-01-17 |
EP0007490A3 (en) | 1980-05-14 |
DE2962192D1 (en) | 1982-03-25 |
JPS5536470A (en) | 1980-03-14 |
ES482128A1 (en) | 1980-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE720T1 (en) | NEW PROSTAGLAND INDIVIDUALS OF THE DELTA-2,4-11-DESOXY-PGE SERIES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS. | |
ES388869A1 (en) | Cephalosporin intermediates and process therefor | |
IE800341L (en) | Imidazoles | |
GB2021589A (en) | Process for Preparation of Compounds Containing Phosphorus-Carbon-Nitrogen Bond | |
ES469703A1 (en) | Process for the preparation of thieno(2,3-c) and thieno(3,2-c) pyridines. | |
SE8005127L (en) | SET TO MAKE 15-HYDROXIIMINO-E-HOMOEBURNAND DERIVATIVES | |
SE7601948L (en) | METHODS OF PRODUCING CARBOXY-ALKANE-PHOSPHONIC ACIDS AND CARBOXY-ALKYL-PHOSPHINIC ACIDS | |
ES455870A1 (en) | Diarylacetamidopropanes processes for producing them and compositions containing them | |
ES8705359A1 (en) | Preparation of N-methyl-1-alkylthio-2-nitroethenamines | |
US3959363A (en) | 15-Ethynyl-PFG2.sub.β | |
IE45609L (en) | Process for the preparation of prostaglandins | |
ES482971A1 (en) | Prostaglandin derivatives of the delta-2-11-desoxy-PGF2 or PGE2 series, their use and process for their preparation, and process for the preparation of medicaments. | |
DK497483A (en) | METHOD AND INTERMEDIATES FOR THE PREPARATION OF 1,1-DIOXOPENICILLANOYLOXYMETHYL-6-BETA-AMINOPENICILLANATE | |
ES485801A1 (en) | Process for preparing cyclo-1,3,2-oxazaphosphoryl derivatives | |
ATE52770T1 (en) | NEW CARBACYCLINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES. | |
ATE18206T1 (en) | PROCEDURE FOR PRODUCTION OF A LACTAME. | |
SU620479A1 (en) | Ethyl ester of n-propylaminoacetic acid and diethyl ester of ethylenediaminotetraacetic acid as selective stationary phase for gas-liquid chromatography | |
JPS5257142A (en) | Process for preparing dihalovinyl-cyclopropanecarboxylic acid derivati ves | |
Strike et al. | 15-Ethynyl-PFG 2 β | |
SU604494A3 (en) | Method of preparing 2,5-dimethyl-thieno-(3,2-f) morphane | |
JPS51125062A (en) | A process for preparing 3-aminoazetidinone | |
JPS56147766A (en) | Preparation of lactam | |
DE19652566A1 (en) | Preparation of 4-methyl-pentanoic acid | |
IE45760L (en) | Prostaglandins | |
JPS55113726A (en) | Preparation of homoisotwistane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee | ||
REN | Ceased due to non-payment of the annual fee |